Font Size:
a
A
A
Keyword [Chimeric antigen receptor T]
Result: 1 - 20 | Page: 1 of 7
1.
Construction Of Chimeric EGFRvⅢ ScFv-CD137-CD3ζ And Selective Killing Effect Of Its Modified T Cells
2.
The Antitumor Experiment Research Of Chimeric EGFRvⅢ ScFv-ICOS-CD3ξ Modified T Cells
3.
Clinical And In Vitro Study On The Anti Leukemia Effect Of Chimeric Antigen Receptor T Cells
4.
PSCA And MUC1 In Non-small-cell Lung Cancer As Targets Of Chimeric Antigen Receptor T Cells
5.
A Preliminary Study Of PD-1-antibody-expressing,Chimeric Antigen-receptor T Cells Targeting Mesothelin In Patients With Malignant Biliary Tumors
6.
Construction And Identification Of PHBLV-BCL2/IgH-CAR Plasmid Of Follicular Lymphoma
7.
Construction And Identification Of PLVX-CD19-CD28-CD137-TCRζ Lentiviral Vector And Its Application In B Cell Leukemia
8.
Construction Of C-Met Target Chimeric Antigen Receptor T Cell And Evaluation For Nasopharyngeal Carcinoma Cells
9.
Research Progress On The Application Of Immunotherapy In Multiple Myeloma
10.
Cytotoxic Effect And Optimization Of Different Antigen Epitope Of CD30-targeted Chimeric Antigen Receptor T Cells In Classical Hodgkin’s Lymphoma Cell Line
11.
The Study Of CD123 On The Prognosis Of Acute Myeloid Leukemia And The In Vitro Cytotoxicity By Chimeric Antigen Receptor T Cells Targeting CD123
12.
The Antitumor Effects Of CAR-T Cells Targeting EpCAM Antigen On Colorectal Cancer
13.
Fabrication Of C-Met Chimeric Antigen Receptor T Cells And Killing Of Hepatocellular Carcinoma Cells In Vitro And In Vivo
14.
Construction And Characterization Of CAR-T Cells Targeting GPC3-Positive Hepatocellular Carcinoma
15.
Development Of CAR-T Cells Targeting AXL And Its Therapeutic Effects On Solid Tumors
16.
Analysis Of The Effect Of CAR-T Cells In Treatment Of Recurrent Refractory DLBCL
17.
Antitumor Effect And Mechanism Of Targeting CD105 Chimeric Antigen Receptor T Cells
18.
Antitumor Efficacy Of NKG2D CAR-T Cells Against Human Colorectal Cancer Cells In Vitro And In Vivo
19.
Construction Of T Cells Expressing Anti-CD19 And Anti-CD22 Antigen Chimeric Antigen Receptor And Their Combined Application In B-cell Malignancies
20.
The Experimental Research About The Effection Of CD19 Chimeric Antigen Receptor T-Cell With Chemotherapy Drugs
<<First
<Prev
Next>
Last>>
Jump to